Robotechnik Intelligent Technology (03757) actual controller, chairman and CEO proposes share repurchase of the company
Robotechnik Intelligent Technology (03757) announced that on October 16, 2026, the company received a letter from Mr. Dai Jun, the company's actual controller, chairman and CEO, proposing a share repurchase of Robotechnik Intelligent Technology Co., Ltd. Mr. Dai Jun proposed that the company use its own funds or self-raised funds to repurchase part of its issued RMB ordinary shares (A shares) through the Shenzhen Stock Exchange trading system by way of centralized bidding, with the total amount of funds for the share repurchase not less than RMB 50 million (inclusive) and not more than RMB 100 million (inclusive).
Robotechnik Intelligent Technology (03757) announced that on October 16, 2026, the company received a letter from Mr. Dai Jun, the company's actual controller, chairman and CEO, titled "Letter Regarding the Proposal for Robotechnik Intelligent Technology Co., Ltd. to Repurchase the Company's Shares." Mr. Dai Jun proposed that the company use its own funds or self-raised funds to repurchase part of the company's already-issued RMB ordinary shares (A shares) through the Shenzhen Stock Exchange trading system by way of centralized bidding, with the total amount of funds for the share repurchase not less than RMB 50 million (inclusive) and not more than RMB 100 million (inclusive).
Based on confidence in the company's future development and recognition of the company's value, in order to enhance investor confidence and safeguard the interests of the broad masses of investors, and in light of the company's operating conditions, business development prospects, financial condition, and future plans for the use of funds, Mr. Dai Jun, the company's actual controller, chairman and CEO, proposed that the company use its own funds or self-raised funds to repurchase part of the company's already-issued RMB ordinary shares (A shares) by way of centralized bidding, and the shares repurchased this time are all intended to be cancelled and to reduce the company's registered capital.
Related Articles

US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.

US Stock Market Move | Selloff Continues as Nasdaq 100 Plunges 1.3%, Most Star Tech Stocks Fall

AI data center construction demand remains strong; Morgan Stanley is bullish on the outlook for Ethernet and optical communications, favoring Lumentum (LITE.US) and Coherent (COHR.US) amid the stock pullback.
US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.

US Stock Market Move | Selloff Continues as Nasdaq 100 Plunges 1.3%, Most Star Tech Stocks Fall

AI data center construction demand remains strong; Morgan Stanley is bullish on the outlook for Ethernet and optical communications, favoring Lumentum (LITE.US) and Coherent (COHR.US) amid the stock pullback.






